跳至主要内容
临床试验/JPRN-jRCT1060220042
JPRN-jRCT1060220042招募中未知

Feasibility study of postoperative adjuvant therapy using S-1 (Tegafur/Gimeracil/Oteracil Potassium) after curative esophagectomy for esophageal cancer

Hirahara Noriyuki0 个研究点目标入组 45 人开始时间: 2022年7月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1) Histologically confirmed esophageal squamous cell carcinoma or adenocarcinoma.
  • 2) Postoperative adjuvant chemotherap using S-a was performed.
  • 3) Curative gastrectomy was performed.
  • 4) Performance status of 0-1 on the Eastern Cooperative Oncology Group classification
  • 5) No prior chemotherapy, radiation, endcrine, molecular targeted therapy within 5 years including treatment for other cancers,
  • 6) Sufficient oral intake.

排除标准

  • (1)Double cancer
  • (2)Heart failure, hepatitis, renal dysfunction
  • (3)Severe infection

研究者

发起方
Hirahara Noriyuki

相似试验